# Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness

> **NCT05903924** · PHASE3 · COMPLETED · sponsor: **Vanda Pharmaceuticals** · enrollment: 316 (actual)

## Conditions studied

- Motion Sickness

## Interventions

- **DRUG:** Tradipitant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05903924
- **Lead sponsor:** Vanda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-09
- **Primary completion:** 2024-04-06
- **Final completion:** 2024-04-24
- **Target enrollment:** 316 (ACTUAL)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05903924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05903924, "Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05903924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*